Insider Transactions in Q1 2025 at Boston Scientific Corp (BSX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 21
2025
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Open market or private sale
|
Direct |
4,826
-9.52%
|
$501,904
$104.64 P/Share
|
|
Feb 20
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Bona fide gift
|
Direct |
1,000
-0.55%
|
-
|
|
Feb 19
2025
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
67,333
-22.97%
|
$7,069,965
$105.24 P/Share
|
|
Feb 19
2025
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
60,523
+5.29%
|
$1,634,121
$27.26 P/Share
|
|
Feb 19
2025
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
1,510
-4.36%
|
$158,550
$105.35 P/Share
|
|
Feb 19
2025
|
John Bradley Sorenson EVP, Global Operations |
SELL
Open market or private sale
|
Direct |
3,303
-13.6%
|
$346,815
$105.19 P/Share
|
|
Feb 18
2025
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
17,530
-3.54%
|
$1,823,120
$104.38 P/Share
|
|
Feb 18
2025
|
John Bradley Sorenson EVP, Global Operations |
SELL
Open market or private sale
|
Direct |
2,657
-9.86%
|
$276,328
$104.41 P/Share
|
|
Feb 17
2025
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,217
-0.88%
|
$235,002
$106.11 P/Share
|
|
Feb 17
2025
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,584
+1.78%
|
-
|
|
Feb 17
2025
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
484
-0.95%
|
$51,304
$106.11 P/Share
|
|
Feb 17
2025
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+1.92%
|
-
|
|
Feb 17
2025
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,315
-5.58%
|
$139,390
$106.11 P/Share
|
|
Feb 17
2025
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,834
+10.74%
|
-
|
|
Feb 17
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
2,057
-1.12%
|
$218,042
$106.11 P/Share
|
|
Feb 17
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
4,167
+2.22%
|
-
|
|
Feb 17
2025
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,865
-0.53%
|
$939,690
$106.11 P/Share
|
|
Feb 17
2025
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,334
+1.09%
|
-
|
|
Feb 17
2025
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
1,521
-4.21%
|
$161,226
$106.11 P/Share
|
|
Feb 17
2025
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
3,334
+8.44%
|
-
|
|
Feb 17
2025
|
Miriam O'Sullivan SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
36
-2.04%
|
$3,816
$106.11 P/Share
|
|
Feb 17
2025
|
Miriam O'Sullivan SVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
100
+5.36%
|
-
|
|
Feb 17
2025
|
Miriam O'Sullivan SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
294
-1.95%
|
$31,164
$106.11 P/Share
|
|
Feb 17
2025
|
Miriam O'Sullivan SVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+6.22%
|
-
|
|
Feb 17
2025
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
684
-2.48%
|
$72,504
$106.11 P/Share
|
|
Feb 17
2025
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+5.15%
|
-
|
|
Feb 17
2025
|
Emily Woodworth SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
283
-6.17%
|
$29,998
$106.11 P/Share
|
|
Feb 17
2025
|
Emily Woodworth SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
667
+12.7%
|
-
|
|
Feb 16
2025
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,052
-0.82%
|
$217,512
$106.11 P/Share
|
|
Feb 16
2025
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,243
+1.67%
|
-
|
|
Feb 16
2025
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
890
-1.74%
|
$94,340
$106.11 P/Share
|
|
Feb 16
2025
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,839
+3.48%
|
-
|
|
Feb 16
2025
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,231
-5.61%
|
$130,486
$106.11 P/Share
|
|
Feb 16
2025
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,546
+10.39%
|
-
|
|
Feb 16
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,806
-1.0%
|
$191,436
$106.11 P/Share
|
|
Feb 16
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,960
+2.14%
|
-
|
|
Feb 16
2025
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,865
-0.48%
|
$833,690
$106.11 P/Share
|
|
Feb 16
2025
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,265
+0.98%
|
-
|
|
Feb 16
2025
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
1,355
-3.96%
|
$143,630
$106.11 P/Share
|
|
Feb 16
2025
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,970
+7.99%
|
-
|
|
Feb 16
2025
|
Miriam O'Sullivan SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
30
-1.77%
|
$3,180
$106.11 P/Share
|
|
Feb 16
2025
|
Miriam O'Sullivan SVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
85
+4.77%
|
-
|
|
Feb 16
2025
|
Miriam O'Sullivan SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
291
-2.03%
|
$30,846
$106.11 P/Share
|
|
Feb 16
2025
|
Miriam O'Sullivan SVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
990
+6.45%
|
-
|
|
Feb 16
2025
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
581
-2.17%
|
$61,586
$106.11 P/Share
|
|
Feb 16
2025
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,273
+4.55%
|
-
|
|
Feb 16
2025
|
Emily Woodworth SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
271
-6.47%
|
$28,726
$106.11 P/Share
|
|
Feb 16
2025
|
Emily Woodworth SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
636
+13.18%
|
-
|
|
Feb 14
2025
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,110
-0.85%
|
$223,660
$106.11 P/Share
|
|
Feb 14
2025
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,362
+1.73%
|
-
|